Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment
- 1,
- 2,
- 3,
- 3,
- 3,
- 3,
- 3,
- 3,
- 3,
- 3*
- 1Centro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro, and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
- 2Pugliese Ciaccio Hospital, Catanzaro, Italy.
- 3Azienda Sanitaria Vibo Valentia, Italy.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Luca Gallelli
Azienda Sanitaria Vibo Valentia, Italy.
Email: gallelli@unicz.it
Copyright: © 2013 The Author(s). This is an open access article.
Abstract
The use of cardiovascular drugs is related to the development of adverse drug reactions (ADRs) in about 24% of the patients in the Cardiovascular Care Unit. Here, we evaluated the ADRs in patients treated with antihypertensive drugs. The study was conducted in two phases: In the first phase, we performed a retrospective study on clinical records of Clinical Divisions (i.e., Internal Medicine Operative Unit and Geriatric Operative Unit) from January 1, 2012 to December 31, 2012. Moreover from January 1, 2013 to March 30, 2013 we performed a prospective study on the outpatients attending the Emergency Department (ED) of the Pugliese-Ciaccio Hospital of Catanzaro, by conducting patient interviews after their informed consent was obtained. The association between a drug and ADR was evaluated using the Naranjo scale. We recorded 72 ADRs in the Clinical Divisions and six in the ED, and these were more frequent in women. Using the Naranjo score, we showed a probable association in 92% of these reactions and a possible association in 8%. The most vulnerable age group involved in ADRs was that of the elderly patients. In conclusion, our results indicate that antihypertensive drugs may be able to induce the development of ADRs, particularly in elderly women receiving multiple drug treatment. Therefore, it is important to motivate the healthcare providers to understand their role and responsibility in the detection, management, documentation, and reporting of ADRs, as also all the essential activities for optimizing patient safety.
Keywords
Subject
Recommended articles
- The safety of ketoprofen in different ages
Claudia Carbone, Pierandrea Rende, Pasquale Comberiati · Journal of Pharmacology and Pharmacotherapeutics
- Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients with Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic
Nor Humaira Mohd Tajudin, Mathumalar Loganathan Fahrni, Rohana Abdul Ghani · Journal of Pharmacology and Pharmacotherapeutics
- Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies
Sweety Sharma, Somnath Basu, Ramesh K. Goyal · Journal of Pharmacology and Pharmacotherapeutics
- Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India
Binit N. Jhaveri, Tejas K. Patel, Manish J. Barvaliya · Journal of Pharmacology and Pharmacotherapeutics
- Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reports
Ilma Bertulyte, Sofie Schwan, Pär Hallberg · Journal of Pharmacology and Pharmacotherapeutics
- Clinical and economic burden of adverse drug reactions
Janet Sultana, Paola Cutroneo, Gianluca Trifirò · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026